Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 118 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.
Singhal D, Kutyna MM, Hahn CN, Shah MV, Hiwase DK
Blood Cancer Discov, 5(6):400-416, 01 Nov 2024
Cited by: 0 articles | PMID: 39422544 | PMCID: PMC11528189
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.
Zerella JR, Homan CC, Arts P, Lin X, Spinelli SJ, Venugopal P, Babic M, Brautigan PJ, Truong L, Arriola-Martinez L, Moore S, Hollins R, Parker WT, Nguyen H, Kassahn KS, Branford S, Feurstein S, Larcher L, Sicre de Fontbrune F, [...] Hahn CN
Blood, 144(17):1765-1780, 01 Oct 2024
Cited by: 0 articles | PMID: 38991192 | PMCID: PMC11530364
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes.
Lim J, Ross DM, Brown AL, Scott HS, Hahn CN
Leuk Res, 146:107566, 25 Aug 2024
Cited by: 0 articles | PMID: 39316992
Add to export list Review
Management of paracondylar process fracture in three horses.
Beldeanu S, Tay MCA, Daniel C, Dosi MCM, Hahn CN, James O, Townsend NB, Liuti T, Schwarz T, Parkinson NJ
Equine Vet J, 56(6):1193-1200, 18 Jul 2024
Cited by: 0 articles | PMID: 39023084
Add to export list
Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.
Venugopal P, Arts P, Fox LC, Simons A, Hiwase DK, Bardy PG, Swift A, Ross DM, van Vulpen LFD, Buijs A, Bolton KL, Getta B, Furlong E, Carter T, Krapels I, Hoeks M, Al Kindy A, Al Kindy F, de Munnik S, [...] Scott HS
Blood Adv, 8(13):3437-3443, 01 Jul 2024
Cited by: 0 articles | PMID: 38662475 | PMCID: PMC11259931
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.
Hong LE, Wechalekar MD, Kutyna M, Small A, Lim K, Thompson-Peach C, Li JJ, Chhetri R, Scott HS, Brown A, Hahn CN, Yeung DT, Sajid S, Robinson N, Thomas R, Branford S, D'Andrea RJ, Samaraweera SE, Patnaik M, [...] Hiwase DK
Blood, 143(18):1873-1877, 01 May 2024
Cited by: 1 article | PMID: 38457663
Add to export list
The 10^th Barossa meeting: Cell Signalling to Cancer Medicine.
Kan WL, McClure BJ, Hahn CN, Powell JA
Cell Death Dis, 15(3):230, 21 Mar 2024
Cited by: 0 articles | PMID: 38514607 | PMCID: PMC10957862
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
Homan CC, Drazer MW, Yu K, Lawrence DM, Feng J, Arriola-Martinez L, Pozsgai MJ, McNeely KE, Ha T, Venugopal P, Arts P, King-Smith SL, Cheah J, Armstrong M, Wang P, Bödör C, Cantor AB, Cazzola M, Degelman E, [...] NISC Comparative Sequencing Program
Blood Adv, 7(20):6092-6107, 01 Oct 2023
Cited by: 10 articles | PMID: 37406166 | PMCID: PMC10582382
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.
Zerella JR, Homan CC, Arts P, Brown AL, Scott HS, Hahn CN
Front Oncol, 13:1183318, 12 Jun 2023
Cited by: 1 article | PMID: 37377909 | PMCID: PMC10291195
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
Shah MV, Tran ENH, Shah S, Chhetri R, Baranwal A, Ladon D, Shultz C, Al-Kali A, Brown AL, Chen D, Scott HS, Greipp P, Thomas D, Alkhateeb HB, Singhal D, Gangat N, Kumar S, Patnaik MM, Hahn CN, [...] Hiwase DK
Blood Cancer J, 13(1):51, 11 Apr 2023
Cited by: 11 articles | PMID: 37041128 | PMCID: PMC10090194
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.
Flerlage JE, Myers JR, Maciaszek JL, Oak N, Rashkin SR, Hui Y, Wang YD, Chen W, Wu G, Chang TC, Hamilton K, Tithi SS, Goldin LR, Rotunno M, Caporaso N, Vogt A, Flamish D, Wyatt K, Liu J, [...] Rampersaud E
Blood, 141(11):1293-1307, 01 Mar 2023
Cited by: 8 articles | PMID: 35977101 | PMCID: PMC10082357
Add to export list Free full text in Europe PMC
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
Saygin C, Roloff G, Hahn CN, Chhetri R, Gill S, Elmariah H, Talati C, Nunley E, Gao G, Kim A, Bishop M, Kosuri S, Das S, Singhal D, Venugopal P, Homan CC, Brown A, Scott HS, Hiwase D, Godley LA
Blood Adv, 7(4):549-554, 01 Feb 2023
Cited by: 16 articles | PMID: 36001442 | PMCID: PMC9979761
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.
Baranwal A, Hahn CN, Shah MV, Hiwase DK
Curr Hematol Malig Rep, 17(6):254-265, 20 Aug 2022
Cited by: 8 articles | PMID: 35986863
Add to export list Review
Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.
Samaraweera SE, Geukens T, Casolari DA, Nguyen T, Sun C, Bailey S, Moore S, Feng J, Schreiber AW, Parker WT, Brown AL, Butcher C, Bardy PG, Osborn M, Scott HS, Talaulikar D, Grove CS, Hahn CN, D'Andrea RJ, Ross DM
Pathology, 55(1):77-85, 05 Aug 2022
Cited by: 0 articles | PMID: 36031433
Add to export list
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations.
Drazer MW, Homan CC, Yu K, Cavalcante de Andrade Silva M, McNeely KE, Pozsgai MJ, Acevedo-Mendez MG, Segal JP, Wang P, Feng J, King-Smith SL, Kim E, Korotev S, Lawrence DM, Schreiber AW, Hahn CN, Scott HS, Sood R, NISC Comparative Sequencing Program, [...] Godley LA
Blood Adv, 6(15):4357-4359, 01 Aug 2022
Cited by: 9 articles | PMID: 35537115 | PMCID: PMC9636309
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema.
Byrne AB, Brouillard P, Sutton DL, Kazenwadel J, Montazaribarforoushi S, Secker GA, Oszmiana A, Babic M, Betterman KL, Brautigan PJ, White M, Piltz SG, Thomas PQ, Hahn CN, Rath M, Felbor U, Korenke GC, Smith CL, Wood KH, [...] Harvey NL
Sci Transl Med, 14(634):eabm4869, 02 Mar 2022
Cited by: 15 articles | PMID: 35235341
Add to export list
A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias.
Feurstein S, Hahn CN, Mehta N, Godley LA
Genet Med, 24(4):931-954, 19 Jan 2022
Cited by: 7 articles | PMID: 35063349
Add to export list
Childhood acute myeloid leukemia shows a high level of germline predisposition.
Samaraweera SE, Wang PPS, Li KL, Casolari DA, Feng J, Pinese M, Maung KZY, Leo P, Cowley M, Perkins K, Smith AM, Ellis J, Wee A, Hiwase DK, Scott HS, Schreiber AW, Brown AL, Deans AJ, Ross DM, [...] D'Andrea RJ
Blood, 138(22):2293-2298, 01 Dec 2021
Cited by: 7 articles | PMID: 34521114
Add to export list
Clonal hematopoiesis in individuals with ANKRD26 or ETV6 germline mutations
Drazer MW, Homan CC, Yu K, de Andrade Silva MC, McNeely KE, Pozsgai MJ, Acevedo MG, Segal JP, Wang P, Feng J, King-Smith SL, Kim E, Korotev SC, Lawrence DM, Schreiber AW, Hahn CN, Scott HS, Sood R, NISC Comparative Sequencing Program, [...] Godley LA
bioRxiv, 22 Nov 2021
Cited by: 0 articles | PPR: PPR424091
Add to export list Preprint
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.
Homan CC, King-Smith SL, Lawrence DM, Arts P, Feng J, Andrews J, Armstrong M, Ha T, Dobbins J, Drazer MW, Yu K, Bödör C, Cantor A, Cazzola M, Degelman E, DiNardo CD, Duployez N, Favier R, Fröhling S, [...] Brown AL
Haematologica, 106(11):3004-3007, 01 Nov 2021
Cited by: 15 articles | PMID: 34233450
Add to export list
GATA2 deficiency syndrome: A decade of discovery.
Homan CC, Venugopal P, Arts P, Shahrin NH, Feurstein S, Rawlings L, Lawrence DM, Andrews J, King-Smith SL, Harvey NL, Brown AL, Scott HS, Hahn CN
Hum Mutat, 42(11):1399-1421, 31 Aug 2021
Cited by: 23 articles | PMID: 34387894 | PMCID: PMC9291163
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.
Singhal D, Hahn CN, Feurstein S, Wee LYA, Moma L, Kutyna MM, Chhetri R, Eshraghi L, Schreiber AW, Feng J, Wang PP, Babic M, Parker WT, Gao S, Moore S, Das S, Thomas D, Pattnaik S, Brown AL, [...] Hiwase DK
Leukemia, 35(11):3245-3256, 13 Apr 2021
Cited by: 32 articles | PMID: 33850299
Add to export list
Implications of the neuroanatomy of the equine thoracolumbar vertebral column with regional anaesthesia and complications following desmotomy of the interspinous ligament.
Derham AM, Schumacher J, O' Leary JM, Kelly G, Hahn CN
Equine Vet J, 53(4):649-655, 15 Feb 2021
Cited by: 1 article | PMID: 33336365
Add to export list Review
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).
Brown AL, Hahn CN, Scott HS
Blood, 136(1):24-35, 01 Jul 2020
Cited by: 52 articles | PMID: 32430494 | PMCID: PMC7332898
Add to export list Review Free full text in Europe PMC
A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.
Fox LC, Tan M, Brown AL, Arts P, Thompson E, Ryland GL, Lickiss J, Scott HS, Poplawski NK, Phillips K, Came NA, James P, Ting SB, Ritchie DS, Szer J, Hahn CN, Schwarer A, Blombery P
Br J Haematol, 190(5):e297-e301, 03 Jun 2020
Cited by: 9 articles | PMID: 32488879
Add to export list

1-25 of 118 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment.

Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.

Germline genetic variants that predispose to myeloproliferative neoplasms and hereditary myeloproliferative phenotypes.

Management of paracondylar process fracture in three horses.

Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion.

IDH-mutant myeloid neoplasms are associated with seronegative rheumatoid arthritis and innate immune activation.

The 10^th Barossa meeting: Cell Signalling to Cancer Medicine.

Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.

Transcription factor genetics and biology in predisposition to bone marrow failure and hematological malignancy.

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.

Role of Germline Predisposition to Therapy-Related Myeloid Neoplasms.

Novel modes of MPL activation in triple-negative myeloproliferative neoplasms.

Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations.

Pathogenic variants in MDFIC cause recessive central conducting lymphatic anomaly with lymphedema.

A practical guide to interpreting germline variants that drive hematopoietic malignancies, bone marrow failure, and chronic cytopenias.

Childhood acute myeloid leukemia shows a high level of germline predisposition.

Clonal hematopoiesis in individuals with ANKRD26 or ETV6 germline mutations

The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.

GATA2 deficiency syndrome: A decade of discovery.

Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer.

Implications of the neuroanatomy of the equine thoracolumbar vertebral column with regional anaesthesia and complications following desmotomy of the interspinous ligament.

Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA).

A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability.

Partnerships & funding